A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Nortriptyline EP Impurity B HCl | CAS 438-59-5 - 请求报价

media.product.imagealternatetextformat.details

Nortriptyline EP Impurity B HCl

SZ目录编号:SZ-N044003
CAS 号
438-59-5
分子式
C19H19N : HCl
分子量
261.4 : 36.5
投资状态
Synthesis on demand
Rel. CAS No303-50-4 (free base)
运输条件 Room Temperature

化学名称 :

异名 :

运输温度 :

HSN编码 :

原产国 :

微笑 :

使用说明:

Nortriptyline EP Impurity B HCl is chemically 3-(5H-Dibenzo[a,d][7]annulen-5-ylidene)-N-methylpropan-1-amine hydrochloride (as per EP). It is also known as Cyclobenzaprine USP Related Compound B ; Norcyclobenzaprine (EP) ; Desmethyl Cyclobenzaprine. Nortriptyline EP Impurity B HCl is supplied with detailed characterization data compliant with regulatory guideline. Nortriptyline EP Impurity B HCl can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Nortriptyline.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

应用与法规使用场景

购买 438-59-5

采购 438-59-5

订购 438-59-5

询问 438-59-5

price of 438-59-5

438-59-5 供应商

438-59-5 制造商

438-59-5 出口商

buy high quality Nortriptyline EP Impurity B HCl

采购 Nortriptyline EP Impurity B HCl

Nortriptyline EP Impurity B HCl 供应商

Nortriptyline EP Impurity B HCl 制造商

Nortriptyline EP Impurity B HCl 价格

订购 Nortriptyline EP Impurity B HCl

询问 Nortriptyline EP Impurity B HCl

Nortriptyline EP Impurity B HCl 成本

Nortriptyline EP Impurity B HCl 供应商

Nortriptyline EP Impurity B HCl 分销商

Nortriptyline EP Impurity B HCl 用于方法验证

Nortriptyline 对照标准

Nortriptyline EP Impurity B HCl 用于ANDA申报

Nortriptyline EP Impurity B HCl 用于强制降解研究

Nortriptyline EP Impurity B HCl 鉴别标准

Nortriptyline EP Impurity B HCl 用于DMF申报

ℹ️

免责声明

SynZeal 在本网站上提供的产品信息是根据发布时的现有理解而提供的。客户在实际购买时有责任评估信息的准确性。

SynZeal 将根据产品规格的新发展或新发现更新这些详细信息,恕不另行通知。

,